Discrepant MR and [18F]Fluoroethyl-l-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure
Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response criteria based on changes of contrast enhancement (i.e., Macdonald criteria). Furthermore, more precise tumor response assessment criteria (i.e....
Saved in:
| Published in: | Case reports in oncology Vol. 5; no. 3; pp. 493 - 497 |
|---|---|
| Main Authors: | , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Basel, Switzerland
S. Karger AG
08-09-2012
Karger Publishers |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response criteria based on changes of contrast enhancement (i.e., Macdonald criteria). Furthermore, more precise tumor response assessment criteria (i.e., RANO criteria), which incorporate nonenhancing T2/FLAIR sequences into Macdonald criteria, may be influenced by other causes of T2/FLAIR hyperintensity (e.g., radiation-induced gliosis). The authors present discrepant MR and [ 18 F]fluoroethyl- l -tyrosine PET imaging findings in a patient with bevacizumab treatment failure. |
|---|---|
| AbstractList | Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response criteria based on changes of contrast enhancement (i.e., Macdonald criteria). Furthermore, more precise tumor response assessment criteria (i.e., RANO criteria), which incorporate nonenhancing T2/FLAIR sequences into Macdonald criteria, may be influenced by other causes of T2/FLAIR hyperintensity (e.g., radiation-induced gliosis). The authors present discrepant MR and [(18)F]fluoroethyl-L-tyrosine PET imaging findings in a patient with bevacizumab treatment failure. Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response criteria based on changes of contrast enhancement (i.e., Macdonald criteria). Furthermore, more precise tumor response assessment criteria (i.e., RANO criteria), which incorporate nonenhancing T2/FLAIR sequences into Macdonald criteria, may be influenced by other causes of T2/FLAIR hyperintensity (e.g., radiation-induced gliosis). The authors present discrepant MR and [18F]fluoroethyl-l-tyrosine PET imaging findings in a patient with bevacizumab treatment failure. Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response criteria based on changes of contrast enhancement (i.e., Macdonald criteria). Furthermore, more precise tumor response assessment criteria (i.e., RANO criteria), which incorporate nonenhancing T2/FLAIR sequences into Macdonald criteria, may be influenced by other causes of T2/FLAIR hyperintensity (e.g., radiation-induced gliosis). The authors present discrepant MR and [ 18 F]fluoroethyl-L-tyrosine PET imaging findings in a patient with bevacizumab treatment failure. |
| Author | Filss, Christian P. Goldbrunner, Roland Langen, Karl-Josef Galldiks, Norbert |
| Author_xml | – sequence: 1 givenname: Norbert surname: Galldiks fullname: Galldiks, Norbert email: n.galldiks@fz-juelich.de – sequence: 2 givenname: Christian P. surname: Filss fullname: Filss, Christian P. – sequence: 3 givenname: Roland surname: Goldbrunner fullname: Goldbrunner, Roland – sequence: 4 givenname: Karl-Josef surname: Langen fullname: Langen, Karl-Josef |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23271997$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkUuLFDEQgIOsuA89eBcJePLQmnemL8I6buvAyi7LeBIJ1Xn0ZO3pHtI9K-OvN9ra7IKHUCH11Req6hQddX3nEXpOyRtKZfmWEMIFEwvyCJ1QpVihpJZH9-7H6HQYbglRpVTyCTpmnGlalvoEbT7EwSa_g27En28wdA5_pYvqW9Xu-9T7cXNoi7ZYH1I_xM7j64s1Xm2hiV2Dq9i5HAccOwz4Gsbos-RHHDf4vb8DG3_ut1DjCmK7T_4pehygHfyzv_EMfaku1stPxeXVx9Xy_LKwQuqxkFYKBpYoIiBwqLmshS-D4mEhghSUOVZLpWsenFzkQykTZMFt6QgNTCt-hlaT1_Vwa3YpbiEdTA_R_HnoU2MgjdG23qigtSqJ9pbWQtUARPlaUecccOJcyK53k2u3r7fe2dxfgvaB9GGmixvT9HeGS5YnrbPg9SSweX5D8mGupcT8Xp2ZV5fZl_c_m8l_u8rAiwn4DqnxaQbm-lf_TS9vribC7HJLvwBSoKtK |
| CitedBy_id | crossref_primary_10_2967_jnumed_116_187047 crossref_primary_10_1186_s13550_019_0542_5 crossref_primary_10_1007_s40278_014_9253_x crossref_primary_10_1371_journal_pone_0100009 crossref_primary_10_20862_0042_4676_2020_101_4_221_234 crossref_primary_10_1007_s00247_018_4232_7 crossref_primary_10_3389_fnins_2016_00260 crossref_primary_10_1093_noajnl_vdz010 crossref_primary_10_1093_neuonc_nov118 crossref_primary_10_1016_j_nicl_2016_12_020 crossref_primary_10_1097_WCO_0000000000000143 crossref_primary_10_2310_7290_2013_00051 crossref_primary_10_2967_jnumed_122_264859 |
| ContentType | Journal Article |
| Copyright | 2012 S. Karger AG, Basel Copyright © 2012 by S. Karger AG, Basel 2012 |
| Copyright_xml | – notice: 2012 S. Karger AG, Basel – notice: Copyright © 2012 by S. Karger AG, Basel 2012 |
| DBID | M-- NPM AAYXX CITATION 5PM DOA |
| DOI | 10.1159/000342480 |
| DatabaseName | Karger Open Access PubMed CrossRef PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1662-6575 |
| EndPage | 497 |
| ExternalDocumentID | oai_doaj_org_article_6f776907ec1b46baa06eb61ddda30ddf 10_1159_000342480 23271997 342480 |
| Genre | Case Reports |
| GroupedDBID | --- 0~B 29B 3O. 4.4 53G 5GY 5VS 6J9 ACGFS ADBBV ADRAZ AEGXH AEYAO AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZPMC BAWUL BCNDV C1A CAG CYUIP DIK E0A E3Z EBS EJD F5P FB. GROUPED_DOAJ GX1 HYE IPNFZ KQ8 M-- M48 M~E O1H O5R O5S OK1 RIG RKO RNS RPM TR2 3V. 7X7 8FI 8FJ ABDBF ABPAZ ABUWG AFKRA BENPR BPHCQ BVXVI CCPQU COF FYUFA HMCUK IAO IHR ITC NPM PQQKQ PROAC UKHRP AAYXX CITATION 5PM |
| ID | FETCH-LOGICAL-c457t-5c542ac0604af3ab35b4e9f63f84f5412d2b567b3fd58fd51124083c9d01f2763 |
| IEDL.DBID | RPM |
| ISSN | 1662-6575 |
| IngestDate | Tue Oct 22 15:16:02 EDT 2024 Tue Sep 17 21:26:43 EDT 2024 Fri Aug 23 02:59:38 EDT 2024 Sat Sep 28 08:35:29 EDT 2024 Thu Sep 05 19:48:48 EDT 2024 Thu Aug 29 12:04:41 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Amino acid PET Volume-of-interest analysis RANO criteria Metabolically active tumor volume [18F]Fluoroethyl-l-tyrosine [18F]Fluoroethyl-L-tyrosine |
| Language | English |
| License | Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c457t-5c542ac0604af3ab35b4e9f63f84f5412d2b567b3fd58fd51124083c9d01f2763 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529567/ |
| PMID | 23271997 |
| PageCount | 5 |
| ParticipantIDs | pubmed_primary_23271997 karger_primary_342480 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3529567 crossref_primary_10_1159_000342480 doaj_primary_oai_doaj_org_article_6f776907ec1b46baa06eb61ddda30ddf |
| PublicationCentury | 2000 |
| PublicationDate | 20120908 |
| PublicationDateYYYYMMDD | 2012-09-08 |
| PublicationDate_xml | – month: 9 year: 2012 text: 20120908 day: 8 |
| PublicationDecade | 2010 |
| PublicationPlace | Basel, Switzerland |
| PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch |
| PublicationTitle | Case reports in oncology |
| PublicationTitleAlternate | Case Rep Oncol |
| PublicationYear | 2012 |
| Publisher | S. Karger AG Karger Publishers |
| Publisher_xml | – name: S. Karger AG – name: Karger Publishers |
| SSID | ssj0069565 |
| Score | 1.9671333 |
| Snippet | Antiangiogenic treatment using bevacizumab may cause difficulties in distinguishing between antivascular and true antitumor effects when using MRI response... |
| SourceID | doaj pubmedcentral crossref pubmed karger |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 493 |
| SubjectTerms | [18F]Fluoroethyl-l-tyrosine Amino acid PET Metabolically active tumor volume Published: September 2012 RANO criteria Volume-of-interest analysis |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYoB9RLVQptt0BlIa4WieNH9shjIzjQIthKlRCK_BQRSxbBLhL99R3b2Wi3l144RJFsx3JmEs838ZfPCB0A6LDCWE90oQxhinKicysILSAZMUozoUKieHYtf_wuT0dBJqff6itwwpI8cDLcofBShgzOmRwu1EplwmmRW2tVkVnr4-ybyUUyleZgAaifdzpCEK8PowwLZUH7cSn6RJF-iDz3gXO9HIJW6ZFL8ab6iD50QBEfpQFuojXXfkIbF91S-Ba6O23gjYdg0s7wxRVWrcU3eVndVpP59GnqwP4TMiHjVxgHtMeXozE-f4hbEuGqib-yPOOmxQpfJmVVHL7I4mP3okzzZ_6gNK5UEzjr2-hXNRqfnJFu2wRiGJczwg1nVJmgiqN8oXTBNXNDLwpfMs9ZTi3VXEhdeMtLOABxMQBiZmiz3FOYbz6j9Xbauq8IQy-l5cqDrQXTNnDaHOQf0GYI54wO0P7CnPVjUseoY1bBh3Vv8wE6DobuGwRB61gAbq47N9f_c_MAbSc39d0sOt_9p_zk6meqqh_DZV-SL_tqQJAykGsGSK54eWV4qzVtcxd1t4uwKCrkt7e4nx30HqAXjWy1chetz57mbg-9e7bz7_FJ_guH6_nK priority: 102 providerName: Directory of Open Access Journals |
| Title | Discrepant MR and [18F]Fluoroethyl-l-Tyrosine PET Imaging Findings in a Patient with Bevacizumab Failure |
| URI | https://karger.com/doi/10.1159/000342480 https://www.ncbi.nlm.nih.gov/pubmed/23271997 https://pubmed.ncbi.nlm.nih.gov/PMC3529567 https://doaj.org/article/6f776907ec1b46baa06eb61ddda30ddf |
| Volume | 5 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZNH8peRrt2W3pDlL2qiWVJdh7bNKaDZQtdBoMxjK6rWeKENCm0v75Hsh3qPe7BGHSz0DnWOUf69AmhT-B0GKGNIyqWmjBJOVGREYTGEIxoqZiQPlC8_Z58_ZnejDxNDm_OwgTQvlbFZTmbX5bFfcBWLue61-DEepPxMPa7UyLpdVAHfMMmRK-mXwE5vKYQAlPdCwwslKX-yjfwHhIPrGjZoEDVD_bnr0devzZEbZDkK6uT7aO3tbuIr6puHaAdW75De-N6Q_wQ3d8U8N-DSSnXeHyHZWnwryjNfmezzWK1sCCFGflCpk_QDyiPJ6Mp_jwPFxPhrAgHWh5wUWKJJxW_KvbrsvjaPkpdPG_mUuFMFh65foR-ZKPp8JbUlycQzXiyJlxzRqX23DjSxVLFXDE7cCJ2KXOcRdRQBWOoYmd4Cg_4XQzcMT0w_chRmHXeo91yUdqPCEMrqeHSGRkLpoxHtlmIQqDMAN592kUXzXDmy4ojIw-xBR_k2-Hvoms_0NsCntY6JCxWf_JauLlw0CqE61ZHoCVKyr6wSkTGwKf7xrguOqrEtG2mafz0n_Th3bcqK1_6ah8qWW6zG03ooqQl5Vb32jmgjIF9u1a-4_-ueYLegNdFA1AtPUW769XGnqHOg9mchxWB86DPL2Iz-aI |
| link.rule.ids | 230,315,729,782,786,866,887,2107,27934,27935,53802,53804 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfYkIAXPgcUBliIV6-JYzvpI-sadaId1SgSEkKRP1lEm1ZdiwR_PWcnqRYe9xBFytmOk7v47uKff0boAwQdRmjjiEqkJkxSTlRsBKEJJCNaKiakTxTHX9KLb9nZyNPk8HYtTADta1WeVIvlSVVeBWzleqn7LU6sP5sOEz87JdL-AboL32tE2yS9HoAFyHhDIgTOuh84WCjL_KZvED-kHlrR8UKBrB880C-Pvb7pirowyRt-J390yx4_Rg-bQBN_rMVP0B1bPUX3ps1U-jN0dVbCiAHOqNri6SWWlcHf4yz_kS92q83Kgv4WZELmf6D_UB7PRnN8vgxbGuG8DEthrnFZYYlnNTMr9n908an9LXX5d7eUCuey9Jj3I_Q1H82HY9Jsu0A04-mWcM0Zldqz6kiXSJVwxezAicRlzHEWU0MVPItKnOEZHBCxMQjk9MBEsaMwXj1Hh9Wqsi8RhlYyw6UzMhFMGY-Js5C_QJkBnCPaQ-9bNRTrml2jCFkJHxR7tfXQqVfQvoAnxA4XVpufRfOSC-GgVUj0rY7BvpSUkbBKxMbArSNjXA8d1erdN9M2fvzf9eHl51pUrH21F7UN7MWtBfVQ2rGOTve6EjCKwNvdGMGrW9d8h-6P59NJMTm_-PQaPYDYjQa4W3aMDrebnX2DDq7N7m34Gv4BaeIOSw |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFLbYkCZeuA7oGGAhXr0kju2kj6xttIl1VKNISAhFvsQsWptWXYsEv55j56KFR3iIIvkWO-fY55z4y2eE3oPTYYQ2lqhYasIk5URFRhAaQzCipWJCukDx7HNy-TUdTxxNTnfUlwfta1WeVIvlSVVee2zleqmDFicWzKaj2O1OiSRYGxvsofswZ0PWBur1IiwgnzdEQmCwA8_DQlnqDn4DHyJx8IqeJfKE_WCFbhz--q456kMl79ie7NF_9Poxetg4nPhDXeQJuldUT9HBtNlSf4auxyWsHGCUqi2eXmFZGfwtSrPv2WK32qwKkOOCXJD5LxgDlMezyRyfL_3RRjgr_S8xt7issMSzmqEVuy-7-LT4KXX5e7eUCmeydNj3Q_Qlm8xHZ6Q5foFoxpMt4ZozKrVj15E2lirmihVDK2KbMstZRA1VMB4VW8NTuMBzY-DQ6aEJI0th3XqO9qtVVbxEGFpJDZfWyFgwZRw2roA4BsoM4R7SAXrXiiJf1ywbuY9O-DDvRDdAp05IXQFHjO0TVpsfefOic2GhVQj4Cx2BnikpQ1EoERkDjw6NsQN0WIu4a6Zt_Piv9NHVpzorX7tqL2o96LJbLRqgpKchve71c0AxPH93owhH_1zzLTqYjbP84vzy4yv0AFw46lFv6THa3252xWu0d2t2b_yE-APzkxDL |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Discrepant+MR+and+%5B18F%5DFluoroethyl-L-Tyrosine+PET+Imaging+Findings+in+a+Patient+with+Bevacizumab+Failure&rft.jtitle=Case+reports+in+oncology&rft.au=Galldiks%2C+Norbert&rft.au=Filss%2C+Christian+P.&rft.au=Goldbrunner%2C+Roland&rft.au=Langen%2C+Karl-Josef&rft.date=2012-09-08&rft.pub=S.+Karger+AG&rft.eissn=1662-6575&rft.volume=5&rft.issue=3&rft.spage=490&rft.epage=494&rft_id=info:doi/10.1159%2F000342480&rft_id=info%3Apmid%2F23271997&rft.externalDBID=PMC3529567 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1662-6575&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1662-6575&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1662-6575&client=summon |